The super blog 6919

Regenerative medicine promises a lot: repair instead of replacement, healing instead of masking symptoms, biologic solutions instead of hardware. I have watched patients cross continents for stem cell injections, platelet-rich plasma (PRP), biologic patches, and gene-leaning therapies, often with hope that far outpaces the available data. The field is exciting, but the marketing is much further along than the science or the policy. When you zoom out from the glossy clinic websites and conference talks, three problems rise to the top: cost, access, and uncertainty about outcomes. Those three, in turn, spill into questions about ethics, regulation, and who actually benefits. This is an honest look at the disadvantages of regenerative medicine, especially for patients trying to decide whether to spend hard-earned money on it. What counts as regenerative medicine, really? The phrase gets used to sell everything from evidence-based biologics to glorified vitamin injections. At its core, regenerative medicine aims to restore or regenerate damaged cells, tissues, or organs rather than simply relieve symptoms. In daily practice, a lot of what patients call “regenerative” tends to fall into a few broad categories: Autologous treatments that use your own tissues, such as: Platelet-rich plasma (PRP) injections Bone marrow aspirate concentrate (BMAC) Adipose (fat) derived cell preparations Allogenic biologics from donors, such as some amniotic products or cord tissue products. More advanced or experimental approaches such as lab-expanded stem cells, gene-modifying therapies, and tissue-engineered constructs. Within this world, you will hear about “regenerative medicine doctors.” That phrase is more of a Regenerative Medicine Doctor Scottsdale functional description than a formal specialty. When patients ask, “What is a regenerative medicine doctor?” they are usually seeing one of several backgrounds: sports medicine physicians, physical medicine and rehabilitation (PM&R) doctors, orthopedists, anesthesiologists with pain medicine training, or even family physicians, all of whom have added training or courses in biologic injections and related procedures. There is no single universal board certification titled “Regenerative Medicine” in the same way there is for cardiology or dermatology. The lack of clear boundaries is part of the problem. It opens a door to creative marketing, uneven training, and inconsistent standards of care. The biggest problem with regenerative medicine: uncertainty, not magic Patients often ask, “What is the biggest problem with regenerative medicine?” expecting to hear “cost.” Cost is massive, but it is not the most fundamental problem. The core issue is uncertainty. Uncertainty shows up in several ways. First, many therapies are marketed far beyond the strength of the evidence. We have encouraging data for certain uses, like PRP for some forms of knee osteoarthritis or tendon problems, but even in those areas results vary. For other conditions, the literature is thin, conflicting, or limited to small non-randomized studies. Second, products are not standardized. One clinic’s “stem cell treatment” can be a basic bone marrow concentrate with variable cell counts. Another might be using a commercially prepared amniotic or cord product that contains very few viable cells. A third, especially outside the United States, may be infusing millions of culture-expanded mesenchymal stem cells. To the patient, all three can sound identical, yet they are biologically and regulatory worlds apart. Third, outcomes are not only uncertain, they are hard to measure. If you inject an arthritic knee and the patient reports 40 percent improvement, is that a success? For some people, yes. For others, anything short of full restoration feels like failure, especially after spending several thousand dollars. This is why the question “What is the success rate of regenerative medicine?” has no honest single answer. Success rates depend on: The specific condition (for example: focal tendon tear versus diffuse advanced arthritis) The exact treatment protocol Patient factors such as age, weight, activity level, and other conditions The definition of success: complete pain relief, partial improvement, delay of surgery, or something else Well-run practices try to collect their own outcome data and publish or at least share aggregated results, but many clinics just lean on anecdote and testimonials. That is not the level of evidence you want when you are paying out of pocket. The money question: cost and physician income Once patients realize insurance usually will not pay, the conversation quickly turns to money. On one side, “What is the average cost of regenerative medicine?” On the other, “How much do regenerative medicine doctors make?” What patients are paying Pricing is extremely variable, but there are some patterns. For PRP injections in a major US city, most patients can expect something in the range of a few hundred dollars up to around 1,500 dollars per treatment site. Complex procedures, such as bone marrow concentrate for a hip or multifocal spinal injections, can range from 3,000 to 8,000 dollars or more for a single treatment episode at reputable US centers. Package deals for multiple joints or repeat injections can run higher. More exotic offerings, such as culture-expanded stem cell protocols in Panama, Mexico, or other countries, often land in the 10,000 to 30,000 dollar range when you include travel and accommodation. When people ask “Where did Joe Rogan get his stem cell treatment?” they are usually referring to his discussions about receiving culture-expanded stem cell therapy in Panama. That type of protocol is not currently allowed in the United States outside of clinical trials, partly because of regulatory concerns and partly because the long-term safety and efficacy data are incomplete. These price tags matter even more because results are uncertain. You are not paying for a guaranteed fix. You are buying a probability curve. What physicians earn On the other side of the equation, people are often curious about the doctors themselves. “How much do regenerative medicine doctors make?” is not an easy question, because again, “regenerative medicine doctor” is not a formal specialty. Income depends primarily on the underlying specialty and practice model. In the United States, orthopedists, interventional pain physicians, and some sports medicine doctors already sit near the upper tiers of physician compensation. Surveys often list orthopedic surgery and some subspecialty surgical fields near the top when people ask “Who is the highest paid doctor specialty?” Neurosurgery, orthopedic surgery, and some interventional cardiology roles frequently appear at the top of income tables. At the lower end, “What is the lowest paying doctor specialty?” tends to point toward pediatrics, family medicine, and some primary care oriented fields, particularly in non-procedural roles. When these clinicians add cash-pay regenerative services, their income potential can rise significantly, but so does their business risk and ethical responsibility. They step into a grey zone where they are both clinician and retailer. That tension can influence practice patterns. If a doctor’s business model leans heavily on high-margin biologics, the pressure to recommend them grows, especially when most patients are paying cash and there is no insurer acting as a gatekeeper. Insurance: why so many patients pay out of pocket The next hard question is obvious: “Will insurance pay for regenerative medicine?” In typical US practice, the answer is usually no, or only in very limited situations. The general pattern is that major insurers consider most regenerative therapies experimental or investigational for many common uses. That label allows them to deny coverage until there is stronger evidence. So when patients ask, “Does insurance cover Kinetix?” or similar branded regenerative products, the practical answer in most settings is that coverage is rare. Kinetix is one of several branded biologic or “regenerative” products, and like many of its peers, it tends to fall on the non-covered side of the policy lines. Some patients may find niche exceptions, employer-based plans, or trial-related coverage, but it is not something you can count on. From the insurer’s perspective, they have to balance potential benefit against cost and evidence. From the patient’s perspective, it feels like being locked out of promising care unless you can write a large check. The lack of coverage creates real inequity. Patients with the means to self-fund can try promising therapies early. Those without resources often wait until they qualify for surgery that is covered. This is one of the quiet, structural disadvantages of regenerative medicine as it is currently deployed: it can widen the gap between wealthy and poor patients. Who is, and is not, a good candidate A fair amount of frustration comes from mismatched expectations. Marketing tends to present regenerative medicine as broadly applicable. In responsible practice, the question “Who is a good candidate for regenerative medicine?” usually has a narrower answer. Good candidates generally share several traits: a clearly defined, structurally plausible problem that biologic therapy might help; a realistic understanding of the odds and limitations; and the ability to complete a full rehabilitation and follow-up plan. For example, a middle-aged runner with a focal patellar tendon tear and preserved joint space on imaging may be a plausible candidate for PRP. A patient with bone-on-bone tricompartmental knee osteoarthritis, severe deformity, and poor overall health might not be. In the second case, even if some symptom relief is possible, the cost and effort may not be justified compared with an eventual joint replacement. Where regenerative medicine can be particularly problematic is in two opposite groups. First, the very healthy and hopeful “biohackers” who chase every new therapy, sometimes well ahead of the evidence. Second, the very ill and desperate, who have exhausted conventional options and are vulnerable to exaggerated promises, especially in less regulated offshore environments. Pain, procedure burden, and the reality of “minimally invasive” Advertisements often describe regenerative injections as virtually painless. The truth is more nuanced, and patients notice it. “Is regenerative medicine painful?” depends on the specific procedure. Simple PRP injections into superficial soft tissues can be moderately uncomfortable but generally tolerable. More involved procedures, such as bone marrow aspiration from the pelvis or deep injections into spinal structures, can be quite painful during and for several days afterwards, even with local anesthesia and light sedation. In many musculoskeletal applications, pain briefly increases before it improves. Patients sometimes experience a “post-injection flare” for 24 to 72 hours. If you walk into this blind, it can be Regenerative Medicine Doctor Scottsdale alarming and can feel like the treatment has made everything worse. There is also the cumulative burden. Some protocols involve multiple injections over weeks, each with its own prep, recovery, and limitations on activity. For a patient juggling work, childcare, and other illnesses, this is not a trivial undertaking. So while these options are less invasive than surgery, they are not free of pain, time cost, or risk. Scientific grey zones: fasting, “cell regeneration,” and hype At the fringes of the regenerative conversation sit ideas that sound simple and appealing. A common one is prolonged fasting. Patients ask, “Does fasting for 72 hours regenerate cells?” after seeing simplified interpretations of animal studies or small human trials about autophagy and immune system reset. There is real science suggesting that calorie restriction and intermittent or prolonged fasting can influence cellular pathways involved in repair and aging. However, extrapolating that into a promise that a 72 hour fast will “regenerate” joints, organs, or generalized “stem cells” is a stretch. For many people, especially those with diabetes, eating disorders, or other medical conditions, a 72 hour fast is not even safe without supervision. This matters because it reflects a broader issue. Regeneration is a powerful metaphor, and marketers often attach that word to everything from diets to supplements to clinic procedures, blurring the line between plausible mechanisms and proven outcomes. The question “What are the 4 types of regeneration?” has a clean answer in a basic biology textbook, where you might see terms like epimorphosis, morphallaxis, compensatory regeneration, and super-regeneration. In human clinical care, the categories are not nearly so neat. We are patching together blood-derived growth factors, stem-like cells, scaffolds, and mechanical offloading strategies into complex treatment packages, and then labeling them with a simple word: regenerative. That simplification is itself a disadvantage. It tempts both doctors and patients to underestimate complexity and overestimate what we know. Geographic inequity: where patients travel and why If you spend any time in patient forums, you will see the recurring question: “What country is best for stem cell treatment?” There is no single correct answer, but the very existence of that question reveals another disadvantage of the current landscape. Countries vary widely in how they regulate stem cell products and advanced biologics. The United States, Canada, much of Western Europe, and other regions have relatively strict frameworks. Culture-expanded cells, especially if they are manipulated beyond minimal processing, usually require approval as biologic drugs or advanced therapy medicinal products. That approval is difficult, slow, and expensive. Other countries have more permissive systems or specific carve-outs that allow clinics to offer treatments that would be restricted elsewhere. Panama, parts of Mexico, and some clinics in Eastern Europe and Asia have become hubs for patients seeking lab-expanded stem cell infusions for orthopedic issues, autoimmune diseases, neurologic disorders, and more. Medical tourism for regenerative therapies introduces its own disadvantages: Quality control is uneven, even within the same country. Follow-up care back home can be fragmented, because local physicians may be unfamiliar with the protocols or skeptical of the clinics. Legal recourse is limited if something goes wrong. Patients can feel stranded between enthusiastic marketing abroad and dismissive attitudes at home. Again, the people most able to take advantage of these options are those with money, time, and the ability to travel internationally. Outcome uncertainty in real life Abstract talk about “variable outcomes” can feel distant, so it helps to ground this in the sorts of scenarios that play out weekly. A middle-aged carpenter spends 5,000 dollars on bone marrow concentrate injections for his lumbar spine, hoping to avoid fusion surgery. Six months later, his pain is 30 percent better, and he can work longer days with fewer pain pills, but he still cannot handle heavy lifting without flares. He is in a grey zone. If you frame it as “surgery delayed and opioids reduced,” it looks like success. If you frame it as “paid 5,000 dollars and still cannot live normally,” it feels disappointing. Another patient, a recreational tennis player with a partial rotator cuff tear, funds a series of PRP injections for 1,200 dollars. Three months later, she is nearly symptom-free and back to her prior level of play. For her, this feels like a miracle, yet if you look at the natural history and rehab data, some patients would have improved with structured therapy alone. Then there are the patients who spend large sums and see no change or even a decline. Those stories are harder to find on clinic websites, but they exist in office visits, on anonymous forums, and in quiet conversations with primary care doctors. The disadvantage is not that regenerative therapies never work. It is that, for many indications, we still struggle to predict reliably who will meaningfully benefit and who is essentially buying an expensive placebo. Ethical tension and marketing pressure The combination of uncertainty, high cost, and direct-to-consumer marketing creates a fertile ground for ethical conflicts. Some clinics offer financing plans, subscription models, or package deals that start to look more like gym memberships than medical care. Sales staff may be employed to “close” patients, using scripts that emphasize potential benefits and downplay experimental status. Outcome statistics, if provided, are sometimes cherry-picked or framed without clear denominators. Regenerative medicine also exists alongside more traditional specialties where income and status differ widely. The knowledge that some colleagues in procedure-heavy specialties rank among “the highest paid doctor specialties,” while others in fields like primary pediatrics sit closer to “the lowest paying doctor specialty,” can subtly influence career decisions and the adoption of high-margin services. Not every physician leans into those incentives, but the system exerts pressure. This environment rewards confident promises more than measured nuance. Patients end up navigating a commercial landscape when they expected a clinical one. Summarizing the key disadvantages Regenerative medicine is not snake oil. It contains some genuinely valuable tools. But if we look squarely at the downside, several themes keep repeating. A simple way to frame the main disadvantages for patients is the following list: High cost with limited or no insurance coverage, which makes therapies inaccessible for many and financially risky for those who try them. Significant uncertainty about outcomes, amplified by variable product quality, uneven training, and a lack of standardized protocols. Geographic and socioeconomic inequities, with wealthier patients able to travel and self-fund options that others cannot reach. Ethical and regulatory grey zones, where optimistic marketing and financial incentives can outrun the evidence, leaving patients to sort hope from hype. The question is not whether regenerative medicine is “good” or “bad.” It is about whether an individual patient, with a specific condition and resources, is better off taking the leap now, waiting for stronger data, or pursuing more conventional options. How to approach a decision, knowing the drawbacks When I talk with patients, I encourage a sober decision-making process. That means asking very direct questions of any practitioner offering regenerative care: What exact product or tissue source are you using, and how is it processed? What is the evidence for this specific treatment in my specific condition? How many patients like me have you treated, and what outcomes have you tracked? What alternatives exist, their costs, and their expected benefits and risks? What will you do if this does not help? The disadvantages of regenerative medicine are real, but so is the potential. Navigating that tension requires skepticism, clear-eyed assessment of cost and risk, and a willingness to walk away from glowing promises that are not backed by data. For now, regenerative therapies occupy an uneasy middle ground: too promising to ignore, too uncertain and costly to embrace without caution. Patients deserve that nuance upfront, before they hand over a credit card in search of regeneration that may or may not arrive.Integrated Spine, Pain and Wellness 7425 E Shea Blvd Suite 102, Scottsdale, AZ 85260 4806608823

Regenerative medicine has gone from fringe topic to locker room conversation in a relatively short time. Professional athletes talk about platelet rich plasma, stem cells, and biologic injections the way they once talked about ice baths and cortisone shots. Weekend warriors are asking whether they should try it instead of surgery. Some patients arrive in clinic already quoting podcasts and YouTube doctors. The core question underneath all of that noise is simple: who actually benefits from regenerative medicine after a sports injury, and who is better served by more traditional treatment? Having worked with injured athletes, from high school midfielders to aging triathletes and a few professionals, I can tell you that candidacy is far more important than hype. The best results usually come from matching the right person and injury to the right technique, at the right time. This article walks through how I think about that decision, and addresses the most common questions people ask on the way to that choice. What is a regenerative medicine doctor? Before you can decide whether you are a candidate, it helps to be clear about who is actually treating you. A “regenerative medicine doctor” is not a single formal specialty. It is usually a physician who has completed residency and board certification in another area, then added extra training in biologic and tissue based therapies. In sports injury care, that base specialty is most often: Physical medicine and rehabilitation (PM&R) Sports medicine (usually family medicine or internal medicine with a sports fellowship) Orthopedic surgery Interventional pain management These physicians learn to use a patient’s own cells, blood components, or biologic products to try to support healing in tendons, ligaments, cartilage, muscle, and bone. Core examples include platelet rich plasma (PRP), bone marrow or adipose derived cell preparations, prolotherapy, and sometimes amniotic or other donor tissue products, depending on regulations. The good ones do not just “do injections.” They evaluate biomechanics, load management, sleep, nutrition, and traditional rehab. Regenerative medicine is a tool in a broader treatment strategy, not a magic standalone fix. People sometimes ask, slightly off topic, how much regenerative medicine doctors make or whether this is one of the highest paid doctor specialties. Income varies widely because much of this care is cash based. A sports medicine physician who does a mix of insurance visits and a modest number of Regenerative Medicine Doctor Scottsdale biologic procedures might earn in the mid to high six figures in the United States. That is usually less than top orthopedic surgeons and interventional cardiologists, who often occupy the “highest paid doctor specialty” lists, and more than some primary care fields that typically fall near the “lowest paying doctor specialty” category. The pay matters mainly because it influences who offers these services and how they are marketed. What are the 4 types of regeneration, and how does that relate to sports injuries? Biologists often describe four general patterns of tissue response: Complete regeneration: the tissue returns almost exactly to its original structure and function. This is common in the liver, rare in cartilage. Incomplete regeneration: the tissue repairs but with some scarring or altered architecture. Think of a healed muscle strain that never quite feels perfect. Compensatory hypertrophy: remaining tissue enlarges to compensate for damaged parts. For example, remaining muscle fibers getting stronger when others are lost. Repair with scar formation: the body closes the gap with fibrous tissue instead of truly rebuilding the original structure. Classic example: ligament tears that heal with scar. Most sports injuries live in the gray zone between incomplete regeneration and scar repair. Regenerative medicine tries to nudge that response toward more organized, functional tissue. For tendinopathy, that means thicker, healthier collagen fibers instead of disorganized, painful scar. For joint cartilage, realistic goals are often slowing further loss and improving the quality of remaining cartilage, not magically regrowing an entirely new surface. Understanding this keeps expectations honest. When you have lost an entire meniscus or have bone on bone arthritis, no biologic injection is going to “restore the knee you had at 18.” The right treatment may reduce pain and improve function, but it works with biology’s constraints. Core question: who is a good candidate for regenerative medicine after sports injury? When I evaluate someone for regenerative treatment, I mentally sort through five layers: the person, the problem, the timing, prior treatments, and their expectations. The person A good candidate usually has decent baseline health and reasonable healing capacity. That does not mean being a perfect specimen. Some of the best responders I have seen are in their 40s and 50s with a long athletic history and a clean commitment to rehab. Smoking, poorly controlled diabetes, significant immune disorders, advanced vascular disease, or heavy systemic steroid use can all blunt healing. None of them is an automatic veto, but they do lower the likelihood of benefit. In those cases, I talk very plainly about probabilities and often focus first on optimizing health basics before paying for expensive injections. Age matters, but not as much as people think. I have seen 60 year olds who look biologically younger than some 35 year olds because they sleep well, manage stress, lift weights, and eat sensibly. For degenerative problems like chronic tendinopathy or early osteoarthritis, biological age counts more than the number on your driver’s license. The problem The specific injury or condition may be the single biggest factor. Typical scenarios where regenerative medicine can be a reasonable option: Chronic tendinopathy: tennis elbow, jumper’s knee, Achilles tendinosis, proximal hamstring tendinopathy Partial ligament tears: some medial collateral ligament (MCL) and ulnar collateral ligament (UCL) injuries, certain ankle ligaments Early to moderate osteoarthritis: especially in the knee, sometimes in hip or shoulder Recalcitrant muscle injuries: hamstring strains or calf tears that plateau with good rehab Small focal cartilage defects in relatively healthy joints Conditions where results tend to be less predictable or often disappointing: Advanced “bone on bone” osteoarthritis with significant deformity Complete ligament ruptures that clearly need surgical reconstruction, such as a fully torn ACL in a cutting athlete Large, chronic rotator cuff tears with major retraction Diffuse, non specific pain without a clear structural diagnosis A key point: imaging and symptoms both matter. An MRI might show a partial tear that looks like a good target, but if the athlete has mild pain and full function, needling that area and injecting biologics may not be wise. Likewise, if the pain pattern does not match imaging, I look harder for missed diagnoses before considering any procedure. The timing Regenerative medicine tends to fit best in two windows. First, subacute injuries that are not healing as expected despite appropriate early treatment. For instance, a high level runner with proximal hamstring pain that has persisted for three or four months despite rest, graded loading, and technique work. Second, chronic problems that have plateaued. Many of my favorite success stories involve athletes who did 3 to 6 months of serious physical therapy, dialed in sleep, reduced training load, and still had a stubborn, focal pain source we could target. Immediate post injury care for most sprains, strains, and minor tears should still be guided by basic principles: protection, early movement, progressive loading, and intelligent return to play. Trying to shortcut this process with an injection in week one often adds risk and cost without proven benefit. Prior treatments and rehab effort This is one of the most honest filters. If someone has not yet done high quality, progressive rehabilitation, they usually are not ready for regenerative therapies. A “good candidate” in my mind has: Completed a proper course of targeted physical therapy, not just three generic sessions Adjusted training volume and intensity based on pain and performance Worked on strength deficits and mobility limitations around the injured area Given those changes at least several weeks, often months, to work I get wary when someone tells me they have “tried everything” but, on closer questioning, never did more than a few visits of passive therapy and some stretching. Expectations and mindset The people who handle regenerative treatment best tend to share a particular mindset. They see the injection as one piece of a larger plan, not as a standalone cure. They are ready to commit to post procedure rehab, often with a few weeks of stepped down activity before rebuilding. They also accept uncertainty. When we talk about what is the success rate of regenerative medicine, honest answers sound like ranges, not guarantees. For example, decent studies of PRP for tennis elbow show meaningful improvement in a majority of patients compared with steroid or placebo, but not everyone improves, and some would have improved with time and exercise alone. Someone who needs a 100 percent promise that they will avoid surgery or be race ready by a specific date is often setting themselves up for frustration, regardless of how good the procedure itself is. A practical checklist: signs you may be a strong candidate Here is one place where a short list actually helps people organize their thoughts. If several of these apply to you, a regenerative consultation may be worthwhile. Your injury has persisted more than 3 months despite serious rehab, load management, and basic traditional treatments. Imaging and clinical exam point to a focal, structurally defined problem that fits common regenerative indications (such as chronic tendon pain or early arthritis). You are generally healthy, or willing to improve modifiable factors like sleep, smoking, and blood sugar. You are prepared for out of pocket costs and understand that insurance may not help much. You are willing to engage fully in post procedure rehab and accept that results are not guaranteed. If not many of these fit, you may still benefit from a visit with a sports medicine physician, but regenerative therapies might not be the starting point. Is regenerative medicine painful? Pain during and after regenerative treatments varies by procedure and by person. PRP injections into superficial tendons are usually uncomfortable but tolerable. There is a brief blood draw, then the injectate is placed with or without ultrasound guidance. Many athletes describe a few seconds of intense ache at the moment of injection, followed by soreness for several days. Non steroidal anti inflammatories are usually avoided because they may interfere with the intended inflammatory signaling, so we use ice, acetaminophen, and activity modification instead. Injections into deep joint spaces or around spinal structures can be more intense. Most clinics use local anesthetic and sometimes light oral or intravenous sedation. I tell patients to expect a few days of feeling worse before they hopefully feel better. Severe pain, spreading redness, or fevers are red flag symptoms that must be evaluated urgently to rule out infection. Bone marrow derived cell procedures involve a harvest from the pelvis, which can be quite sore for a week or two. In my experience, people tolerate this better than they fear it beforehand, but it is not a casual, “walk out and forget” process. So is regenerative medicine painful? There is discomfort, sometimes significant in the short term, but for most athletes it is manageable and temporary. Proper preparation, clear expectations, and a good proceduralist make a big difference. What is the biggest problem with regenerative medicine? If I had to name a single biggest problem, it would be mismatch: between marketing and evidence, between price and proven value, and between patient expectations and realistic outcomes. Several factors feed that: Evidence quality is uneven. PRP for tennis elbow and knee osteoarthritis has better support than many newer, more expensive “stem cell” packages, yet clinics often push the pricier option. Terminology is abused. Many things get labeled “stem cell therapy” when, under current regulations in the United States and similar countries, they actually involve minimally manipulated bone marrow or fat derived cells with uncertain stem cell content. Costs are often high and opaque. People pay thousands of dollars out of pocket without clear odds of benefit. Regulations lag behind innovation. This opens the door for clinics, especially in poorly regulated environments, to make claims that outpace what peer reviewed studies support. Ethically grounded physicians handle this by talking openly about uncertainties, by refusing to oversell unproven products, and by integrating regenerative techniques within standard care instead of presenting them as miracle alternatives. What are the disadvantages of regenerative medicine? Because this question comes up often, it is useful to lay out the main downsides in a structured way. Cost: Without reliable insurance coverage, out of pocket expenses add up quickly, especially for protocols that involve multiple injections. Variable evidence: Some indications are well studied, others are still experimental. Patients can end up paying for treatments whose benefit over placebo is unproven. Time and disruption: There is usually a recovery window with reduced training, sometimes for several weeks, which can conflict with competition schedules. Risk of complications: While major problems are rare in experienced hands, infections, bleeding, nerve irritation, and post injection flares do occur. Opportunity cost: Focusing on biologics sometimes delays or distracts from interventions that might help more, such as well designed strength programs or timely surgery. Notice that none of these criticisms say the therapies never work. They say you have to be careful about when and how you use them. Costs, insurance, and the practical side of paying for care When people ask, “Will insurance pay for regenerative medicine?” the honest answer right now is “rarely, and only for specific situations.” Most commercial insurers in the United States still classify PRP, bone marrow concentrate, adipose derived cell procedures, and many donor tissue products as experimental or investigational for musculoskeletal conditions. That means they do not cover the procedure costs, though they may pay for associated imaging, physical therapy, or basic joint injections with corticosteroids or hyaluronic acid. What is the average cost of regenerative medicine for sports injuries? Numbers vary by region and practice type, but typical ranges look like this: PRP: often 500 to 2,500 USD per session, depending on concentration systems, body region, and whether ultrasound guidance is used. Bone marrow derived cell procedures: often 3,000 to 8,000 USD or more, especially if multiple sites are treated. Adipose derived procedures: in similar ranges, though these are more constrained by regulatory scrutiny. Some branded protocols, such as Kinetix, bundle evaluation, imaging, biologic preparation, and injection into a package price. People often ask, “Does insurance cover Kinetix?” or similar named programs. The usual pattern is that the branded regenerative components are cash pay, while surrounding conventional care might be billable to insurance. The only way to know is to ask both the clinic and your insurer specific, code based questions in advance. Given the numbers involved, I encourage patients to weigh expected benefit carefully. If 1,500 USD spent on a high quality strength coach, three more months of targeted PT, imaging, and a carefully monitored return to sport would likely get you as far as an injection, start there. Save cash based biologics for situations where they clearly add something distinct. What is the success rate of regenerative medicine? There is no single percentage that applies across all uses. Instead, think in terms of “how strong is the evidence for this specific therapy, for this specific condition, in someone like me?” Examples, based on current data as of the mid 2020s: Lateral epicondylitis (tennis elbow): multiple randomized trials suggest that PRP can outperform corticosteroid injections and placebo over 6 to 12 months, with a majority of patients reporting meaningful improvement. Not 100 percent, but significantly better odds than natural history alone. Knee osteoarthritis: meta analyses indicate that PRP can improve pain and function compared to placebo and often to hyaluronic acid, particularly in early to moderate disease. Benefits appear to wane over 12 to 24 months, which is not surprising given the progressive nature of arthritis. Achilles and patellar tendinopathy: mixed results. Some trials show modest benefit, others find no significant difference from placebo when both groups do good exercise programs. Technique, patient selection, and rehab quality seem to matter. For newer “stem cell” style interventions, where people ask “What country is best for stem cell treatment?” or chase clinics abroad, high quality comparative trials are scarce. Some countries market themselves as leaders, but much of that reputation comes from looser regulation rather than indisputable superior outcomes. If a clinic in another country offers something far outside what is allowed under FDA or EMA rules, be particularly cautious. Ask what peer reviewed data exists and what specific cell counts and product characteristics they can document. In practice, I frame success rates in Regenerative Medicine Doctor Scottsdale ranges. For a well indicated PRP treatment of chronic tennis elbow in a healthy middle aged athlete, I might discuss a ballpark 60 to 80 percent chance of meaningful improvement, a smaller chance of minimal change, and a small risk of being worse in the short term due to flare. For off label, poorly studied applications, I do not quote percentages at all. I describe it as exploratory and only consider it after more established options are exhausted. Fasting, biohacks, and what actually regenerates cells Another keyword that often surfaces online is, “Does fasting for 72 hours regenerate cells?” There are intriguing animal studies showing that prolonged fasting can trigger stem cell activation and immune system remodeling in mice. Some early human data suggests potential metabolic and inflammatory benefits of intermittent fasting and periodic prolonged fasting in specific contexts. That said, we are far from being able to prescribe “three days of fasting equals X percent better tendon healing” in a responsible way. For athletes, extended fasting around the time of injury or heavy training can also impair recovery by depriving muscle and connective tissue of needed nutrients. As with most biohacks, the basics still dominate results: enough high quality protein, sufficient calories for healing, micronutrients from a varied diet, 7 to 9 hours of sleep for most adults, and intelligent load management. These are the quiet but powerful drivers of cellular regeneration that do not require hashtags or exotic supplements. Celebrity stories: where did Joe Rogan get his stem cell treatment? Many patients bring up famous cases. A common one is Joe Rogan, who has talked publicly about traveling to Panama for stem cell treatment, reportedly at a clinic that offers high dose intravenous and possibly intra articular infusions of cultured mesenchymal stem cells derived from donor tissue. Stories like his are interesting but not a guide for the average athlete. People with large platforms often have access to experimental protocols, concierge physicians, and repeated follow up that most patients do not. Their anecdotes also rarely include granular details: exact diagnosis, imaging before and after, standardized outcome scores, other concurrent treatments, and natural history. When someone cites a celebrity recovery, I take it as a sign they are motivated and hopeful, not as clinical evidence. Then we pivot back to their specific case and what is known, probable, and affordable. How doctor incentives shape what you are offered Since a few of the keywords touch physician income, it is worth recognizing how financial structures influence care. Regenerative procedures are lucrative for some practices, especially in markets where insured reimbursement for traditional visits is shrinking. A clinic that can charge 3,000 to 6,000 USD per patient for a series of injections has strong motivation to present those injections as the centerpiece of treatment. This does not mean every high priced procedure is a scam. It does mean you should be alert to how options are framed. If a physician downplays physical therapy, strength training, and conservative management, or if surgery and injections are the only two choices ever mentioned, seek a second opinion. Interestingly, some of the highest paid doctor specialties overall, like orthopedic surgery and certain procedural cardiology subspecialties, have less financial need to push unproven biologics because their core surgeries are already well compensated. Some lower paying fields that move into regenerative work do so out of genuine interest, though the cash pay aspect can be tempting there as well. None of this is inherently bad, but it is the backdrop against which “medical advice” is offered. Pulling it together A good candidate for regenerative medicine after a sports injury is not simply someone who is injured and can pay. It is someone whose specific diagnosis fits what biologic therapies can plausibly help, who has already invested seriously in foundational rehab, who has enough health and healing capacity to respond, and who understands both the potential and the limits of these treatments. On the physician side, the best regenerative medicine doctors integrate these tools into thorough, evidence based care instead of marketing them as standalone miracles. They are transparent about costs and success rates, skeptical of overblown claims, and comfortable saying “no” when the odds of meaningful benefit are low. If you find yourself at that crossroads, ask for a detailed explanation of your diagnosis, the rationale for any proposed regenerative therapy, what high quality alternatives exist, and what concrete outcomes you can reasonably expect over the next year. Then decide not just with your wallet and your hopes, but with a clear view of what your own body, in your own circumstances, is likely to do.Integrated Spine, Pain and Wellness 7425 E Shea Blvd Suite 102, Scottsdale, AZ 85260 4806608823

When people ask, “Is regenerative medicine painful?” they usually are not just curious about discomfort. They are trying to weigh hope against fear. They want to know whether the promise of healing is worth the needles, the downtime, and the bill that almost always lands outside insurance. I have sat across from patients who could not climb stairs without wincing, athletes desperate to avoid surgery, and grandparents trying to get through a grandchild’s wedding without limping. The same questions come up every week: How bad does it hurt? How long does it last? Does it actually work? Let’s walk through what patients really experience, where the pain shows up, and how to judge if these treatments make sense for you. What a regenerative medicine doctor actually does People often start by asking, “What is a regenerative medicine doctor?” It is not a single board-certified specialty like cardiology or dermatology. Instead, it is an area of practice that sits on top of other core specialties. Most physicians who focus on regenerative medicine come from: Physical medicine and rehabilitation Sports medicine Orthopedic surgery Interventional pain management Rheumatology They use tools like platelet-rich plasma (PRP), bone marrow concentrate, fat-derived cell preparations, and sometimes biologic scaffolds to help the body repair or modulate damaged tissues. A good regenerative medicine doctor does more than inject something “special” into a sore joint. They: Diagnose the actual source of pain using exam and imaging Decide if a regenerative approach fits the condition and the patient Choose the right biologic preparation and guide the injection precisely, often with ultrasound or fluoroscopy Plan rehab around the procedure so the new tissue or improved environment actually has a chance to take hold Financially, patients sometimes ask, “How much do regenerative medicine doctors make?” There is no single number. A sports medicine physician who occasionally offers PRP inside a large health system might earn in the range of a typical non-surgical specialist, often around 220,000 to 350,000 USD annually. A high-volume private clinic doing only cash-pay regenerative procedures can generate more revenue, but overhead, staff, and malpractice costs are also higher. It is far from a guaranteed goldmine, and income varies widely by region and practice model. Compared with broader physician income data, the highest paid doctor specialty tends to be neurosurgery or thoracic surgery in most American surveys, often exceeding 700,000 USD annually in busy practices. At the other end, the lowest paying doctor specialty is usually primary care fields like pediatrics or family medicine, frequently under 250,000 USD per year. Those numbers matter because they shape the market around regenerative medicine, including why some clinics push aggressive marketing or inflated promises. Understanding that context helps patients separate trustworthy care from sales tactics. Where the pain actually comes from Most patients picture one big painful moment. In reality, discomfort around regenerative medicine usually falls into three windows: The harvest or collection The injection itself The “flare” period afterward, as the body responds Each window feels different depending on the procedure. PRP: blood draw plus focused soreness Platelet-rich plasma starts like a basic lab test. The blood draw itself feels like any routine venipuncture. For almost everyone, that part is low on the pain scale. Once the blood is spun down and the PRP is prepared, it is injected back into the target area. Here the experience diverges based on location. For a knee joint, I usually warn patients that there will be 10 to 30 seconds of sharp pressure as the fluid goes in, then a feeling like the joint is fuller or tight. With a good local anesthetic and gentle technique, many describe it as “uncomfortable but tolerable.” People who are needle-phobic feel it more intensely, mentally and physically. Tendon or ligament injections, such as for tennis elbow or Achilles tendinopathy, can feel sharper. The needles are going into already irritated tissue. For those patients, numbing the skin and deeper tissues helps, but there is still a period of strong ache as the PRP is dispersed. Once the numbing medicine wears off, the area often feels more sore for 24 to 72 hours, then gradually eases. Most people do not describe PRP as agony, but they do notice a clear spike in discomfort for a few days. Oral pain medication, icing (when allowed by the protocol), and relative rest usually manage this well. Bone marrow and fat-derived preparations: harvest is the main hurdle When patients ask if “stem cell treatments” are painful, they are usually talking about two parts: taking cells out and putting them back in. Technically, in most orthopedic clinics in the United States, the cells used are not the expanded laboratory stem cells available in other countries, but rather “minimally manipulated” concentrates from bone marrow or fat. Bone marrow aspiration, most often from the back of the pelvic bone, is the step people fear. Here is the practical reality: With proper local anesthesia down to the bone surface, the skin and superficial tissues are well numbed. The pressure of the needle entering the bone is odd, more a deep push than a sharp stab. The real intensity comes when the physician aspirates the marrow. Patients often feel a crampy, pulling sensation in the low back or buttock, sometimes radiating down the leg. That part lasts seconds, but can be memorable. About 20 to 30 percent of patients describe that aspirate moment as “quite painful but brief.” Another half call it “weird pressure, not fun but manageable.” A small minority have very little discomfort. Sedation, when available and appropriate, makes this significantly easier, particularly for anxious patients. Fat-derived cell harvest, usually from the abdomen or flanks, feels similar to minor liposuction. With good numbing, the motion of the cannula is mostly pressure and vibration. Afterward, bruising and soreness across the harvest area can last several days. The subsequent injection of marrow or fat concentrate into a joint or tendon feels somewhat similar to PRP, though the volume and viscosity of what is injected can add to the sense of pressure. Prolotherapy: more needle work, more short-term ache Prolotherapy involves injecting an irritant solution, often dextrose-based, into ligaments and tendon insertions. The pain profile is defined by multiple small needle sticks around a joint or along the spine. Patients tolerate this range fairly well, but the aggregate of multiple injections does add up. The following 48 to 72 hours are frequently more painful than the days after a single PRP injection, because the whole point of prolotherapy is to create an inflammatory response. For some, that flare is modest. For others, especially in the low back or sacroiliac region, it can feel like a strong, deep bruise that makes certain movements unpleasant for several days. Non-injection regenerative approaches: shockwave and beyond Not every regenerative technique uses needles. Extracorporeal shockwave therapy is a common example, especially for plantar fasciitis, tennis elbow, and chronic tendon problems. Shockwave treatments sting. The device delivers rapid pressure waves into the tissue. Early sessions often feel like repeated snapping against the skin and deep ache in the tendon. As intensity is increased over a course of therapy, people adapt, but few would call it comfortable. Sessions are short, though, typically under 20 minutes, and there is no needle anxiety. Other modalities, such as low-level laser or certain biologically active scaffolds, usually cause less acute pain, though they may still trigger a mild flare as tissues respond. What most patients actually feel: a realistic pain spectrum Individual tolerance varies, but after watching hundreds of patients go through regenerative procedures, a pattern emerges. On a 0 to 10 pain scale, where 0 is nothing and 10 is unbearable, most orthopedic regenerative therapies live in the 3 to 7 range during the procedure, and 2 to 6 in the days that follow. Here is a broad, experience-based summary: Numbing shots and blood draws hover around 1 to 3 for most people. Joint injections (PRP or similar) usually sit around 3 to 6 during the needle and pressure portion, with a “heavy ache” afterward. Bone marrow aspiration can spike to 6 to 8 for several seconds if done without sedation, though it is brief. The post-procedure flare, especially for PRP and prolotherapy, bothers people most in the first 72 hours, then steps down gradually. Importantly, pain is more than sensation. Anxiety amplifies everything. Patients who come in terrified of needles experience the same physical stimuli as sharper and more overwhelming. Those who understand what will happen, have coping strategies, and trust their physician tend to rate the same procedures lower on the pain scale. When I counsel patients, I frame regenerative medicine as “short-term controlled discomfort in exchange for a chance at long-term function,” not as a painless miracle. Who is a good candidate for regenerative medicine? Not every person with joint or tendon pain should rush toward PRP or bone marrow injections. Some conditions respond beautifully. Others show modest benefit at best. A few are simply not good indications. Research and day-to-day practice roughly agree on the following patterns: Mild to moderate osteoarthritis of the knee, hip, or shoulder often responds reasonably well to PRP and related approaches, especially in younger or middle-aged patients who still have preserved joint space. Focal tendon problems, like lateral epicondylitis (tennis elbow), patellar tendinopathy, and plantar fasciitis, often improve with PRP or shockwave after conservative rehab has failed. Advanced, bone-on-bone arthritis, large structural tears, or joints already severely deformed typically have lower success rates. Sometimes the best option really is joint replacement. Age, general health, metabolic conditions, smoking status, and activity level all influence outcomes. Someone asking, “Who is a good candidate for regenerative medicine?” needs a detailed conversation, not a website quiz. A practical checklist many of my colleagues use informally looks like this: The diagnosis is clear and matches what regenerative therapies can plausibly help. Conservative care such as physical therapy, activity modification, and simple injections has been tried and either plateaued or failed. The patient can tolerate several days of increased pain and reduced activity to give the treatment a fair shot. There is realistic understanding of success rates and no expectation of an instant cure. Speaking of outcomes, patients frequently ask, “What is the success rate of regenerative medicine?” The honest answer is that it depends on the specific treatment and body region. For knee osteoarthritis, for example, randomized trials of PRP show that around 60 to 80 percent of patients achieve meaningful pain improvement at 6 to 12 months, often better than hyaluronic acid injections but not a miracle fix. For tendinopathies, the range is similar, with some studies reporting 70 percent or higher satisfaction, while others show more modest benefit. For bone marrow and fat-based preparations, high quality data are fewer, and reported success varies widely, from 40 percent up to 80 percent or more, depending on definition and patient selection. Anyone promising a 100 percent cure rate is selling something, not practicing medicine. The biggest problems and disadvantages of regenerative medicine Alongside pain, people deserve an honest answer to “What is the biggest problem with regenerative medicine?” and “What are the disadvantages of regenerative medicine?” Several stand out. The first is evidence quality. While the field has grown rapidly, the research is still uneven. There are good randomized trials for some uses of PRP, but far fewer for bone marrow or adipose cell preparations in orthopedic indications. Many protocols are based on small studies, case series, or expert experience rather than large, definitive trials. The second is variability. “PRP” is not one thing. Platelet concentration, presence or absence of white blood cells, activation method, and injection technique all differ between clinics. The same is true, to an even greater extent, for so-called “stem cell” treatments. This makes it hard for patients to know what they are really getting, and hard for doctors to compare outcomes. The third is cost. Most of these procedures are cash-pay. When people ask, “What is the average cost of regenerative medicine?” they usually mean Regenerative Medicine Doctor Scottsdale orthopedic PRP or marrow/fat procedures. In many parts of the United States, a single PRP injection into a joint ranges from about 500 to 1,500 USD. Bone marrow concentrate injections into a major joint Regenerative Medicine Doctor Scottsdale can run from 2,500 up to 6,000 USD or more, especially when multiple joints or areas are treated. This naturally leads to the insurance question: “Will insurance pay for regenerative medicine?” In general, health insurance in the United States does not cover PRP, bone marrow concentrate, or adipose-derived cell injections for orthopedic use. A handful of plans cover PRP for specific indications like chronic lateral epicondylitis, but that is the exception. Patients asking “Does insurance cover Kinetix?” usually learn that branded protocols like Kinetix are treated as elective, not covered medical care. Policies vary a little by carrier, but the default position is non-coverage. The fourth problem is regulatory and ethical inconsistency. Some clinics advertise stem cell cures for nearly every condition under the sun, from autism to dementia, without solid evidence. Others enroll patients into research registries and report outcomes transparently. Patients often cannot tell the difference. Regarding, “What country is best for stem cell treatment?” the honest medical answer is that no country holds a magic key. Some nations, like Panama, have allowed expanded mesenchymal stem cell therapies under regulation that is less restrictive than in the United States. This is one reason high-profile figures such as Joe Rogan have traveled there for infusions. Public reports place his stem cell treatment at the Stem Cell Institute in Panama City. That does not mean Panama is objectively “best.” It means its laws permit treatments that are still under tighter restriction in the U.S., Europe, and other regions. The final disadvantage is that regenerative medicine is not benign simply because it comes “from your own body.” Infections, nerve irritation, bleeding, and worsened pain can occur if procedures are done poorly or on the wrong patients. While major complications are uncommon in capable hands, repeated failed procedures cost money, time, and hope. What about fasting and “natural” regeneration? The phrase “Does fasting for 72 hours regenerate cells?” shows up in online discussions alongside stem cells and PRP. The connection comes from animal studies and small human studies suggesting that extended fasting can influence immune cells and hematopoietic stem cells. In mice, prolonged fasting cycles have shown some regeneration of immune cell populations in the bone marrow and blood. In humans, evidence is more limited. A few small trials suggest that multi-day fasts may shift white blood cell counts and metabolic markers, but claiming that a 72-hour fast “regenerates cells” in a clinically meaningful way stretches the data. From a practical standpoint: Short-term fasting can be safe for healthy adults if done carefully. It should be avoided or medically supervised in people with diabetes, eating disorders, significant cardiovascular disease, pregnancy, or frailty. Any benefit on tissue repair or joint pain is theoretical at this point, not a substitute for targeted regenerative therapies. Food, sleep, and exercise do influence your body’s intrinsic regeneration, but they do so gradually and systemically, not as dramatic on-off switches. Understanding “regeneration”: medical and biological types The phrase “What are the 4 types of regeneration?” usually comes from biology textbooks, not clinic brochures. In classical terms, scientists talk about: Morphallaxis, where an organism reconstructs lost parts mainly by remodeling existing tissue, as in hydra. Epimorphic regeneration, where cells at the wound site de-differentiate and proliferate to rebuild structures, such as salamander limb regrowth. Compensatory regeneration, where remaining cells grow or divide to restore function without recreating the exact original structure, like liver regrowth in humans. Super-regeneration or aberrant regeneration, where healing overshoots or misdirects, leading to structures that do not match the original. In human medicine, we rarely use those exact labels in conversation with patients. Instead, we think in terms of cell-level repair, tissue-level repair, and organ-level adaptation. Regenerative medicine tries to push our limited human capacity a little closer to the impressive feats seen in simpler organisms, but within clear constraints. PRP, marrow aspirate, and similar treatments typically work by modulating inflammation and improving the microenvironment for cells that are already there. They do not regrow entire joints or ligaments from scratch. That is an important expectation to set, especially when the term “stem cell” evokes images of salamander-like limb regrowth. How painful is it relative to surgery and standard injections? Patients often try to compare regenerative procedures with something they understand better, like corticosteroid injections or arthroscopic surgery. Compared with standard steroid shots, regenerative injections usually hurt more and for longer. A cortisone injection may sting briefly, but it often provides pain relief within hours to days. PRP and similar therapies bring more post-injection ache because they lack anesthetic steroids and are designed to provoke a healing response. Compared with arthroscopic surgery, on the other hand, regenerative procedures are clearly less invasive. There is no general anesthesia, no portals into the joint under fluid pressure, and no surgical trauma to tissue beyond the needle tracks. Recovery timelines differ too. A patient might be on crutches for a few days after a bone marrow concentrate injection into a knee, versus several weeks of structured rehab after meniscus surgery. Pain intensity over time tends to be lower with injections than with elective orthopedic operations, though the relief is less certain. For many patients, regenerative medicine occupies a middle ground: more discomfort than conservative care, less than surgery. Whether that trade makes sense depends on the specific diagnosis, expectations, and financial realities. Making a decision you can live with The most useful conversations about regenerative medicine rarely start with technology. They start with the person in front of you. Someone with a mild knee arthritis, a job that allows flexible movement, and a strong desire to avoid steroids might happily accept a few days of increased pain and a 1,000 to 1,500 dollar bill for a reasonable shot at 50 to 70 percent pain reduction. Another person, with more advanced joint damage, limited funds, and a job that demands heavy labor, might be better served by bracing, medications, and planning toward joint replacement instead of speculative biologic injections. A few closing practical points for anyone weighing these treatments: Pain is real, but usually manageable with clear expectations, proper numbing, and short-term medication. The most intense moments are brief. The more severe your joint damage, the lower your chance of dramatic benefit, and the more the pain and cost might feel wasted. Ask your physician exactly what product will be used, how it is prepared, and how many similar procedures they have personally done. Technique affects both pain and success. Be wary of any clinic that promises guaranteed outcomes or claims that their proprietary mix is far superior to everything else without data. Regenerative medicine is not painless, not uniformly proven, and not cheap. Yet in the right patient, for the right problem, it can deliver meaningful, lasting relief with fewer long-term risks than chronic steroid injections or premature surgery. The key is to walk into the process fully informed, prepared for some short-term discomfort, and clear about both the potential and the limits of what your own biology, carefully nudged, can do. Integrated Spine, Pain and Wellness 7425 E Shea Blvd Suite 102, Scottsdale, AZ 85260 4806608823

Every few months a new claim cycles through health podcasts and social media: if you fast for 72 hours, your body will “reset,” your immune system will “rebuild,” and you will “regenerate” new cells as if you had a new lease on life. There is a grain of truth buried inside that promise, but it is surrounded by a lot of wishful thinking and marketing language. As a physician who works with metabolic health and regenerative medicine, I see both sides: the genuinely exciting science and the very real risks when people treat early data as settled fact. This article walks through what we actually know about 72 hour fasting, autophagy, stem cells, and “regeneration,” and how that intersects with the broader field of regenerative medicine. I will also address practical questions patients often ask me, including cost, insurance, discomfort, and who is and is not a good candidate. What “cell regeneration” really means The phrase “cell regeneration” gets used loosely. In biology and in clinical practice, it usually means one of three things. First, routine cellular turnover. Your gut lining renews roughly every few days, your skin over several weeks, and your red blood cells every 3 months or so. This is normal physiology, not a special hack. Second, repair after injury. When your liver is damaged by alcohol or toxins, it can regenerate large portions of itself if the injury is not too advanced. Skeletal muscle, bone, and even some heart tissue can remodel after damage, although not perfectly. Third, true regenerative processes. In research laboratories, scientists talk about regeneration at several levels. A simple textbook breakdown of the 4 types of regeneration includes: Epimorphosis, where cells at the injury site de-differentiate and form a blastema that regrows a lost structure, as in salamander limb regrowth. Morphallaxis, where remaining tissue reorganizes to form a smaller but complete organism, as in some hydra species. Compensatory regeneration, where remaining cells divide to restore function without forming a blastema, as seen in mammalian liver regeneration. Cellular regeneration, where specific cell populations, often stem or progenitor cells, repopulate damaged tissue. Humans have limited epimorphic ability compared to animals like salamanders, but we do use compensatory and cellular regeneration constantly. The excitement around fasting comes from its potential to push the body toward more efficient cellular cleanup and renewal, especially through autophagy and stem cell activation. What happens in a 72 hour fast In my practice, I rarely recommend an unsupervised water-only 72 hour fast, especially for first timers. But to understand why people are drawn to it, you need a clear view of the physiology. The human body stores energy first as glycogen in liver and muscle, and second as fat. Short fasts mostly deplete glycogen. By around 24 hours without calories, most people have burned through a substantial portion of liver glycogen and are relying more heavily on fat stores, producing ketones as an alternative fuel. Between roughly 24 and 72 hours, several important shifts occur: Glucose and insulin fall. Lower insulin means less anabolic signaling and more catabolic cleanup. For those with insulin resistance, this period can feel surprisingly stable once they get over the first day. Ketones rise. Beta-hydroxybutyrate, a primary ketone, increases and serves as fuel for the brain and muscles. Many people report better mental clarity and reduced hunger once they are fully in ketosis. Autophagy becomes more active. Autophagy is an intracellular housekeeping process where cells break down damaged proteins and organelles. Nutrient deprivation is one of the stronger triggers. Most of the detailed autophagy data comes from animal and cell models, but indirect markers in humans suggest that fasting and significant caloric restriction increase autophagic activity. Immune cell dynamics shift. This is where the “immune regeneration” headlines come from. In mouse studies, repeated cycles of prolonged fasting have been shown to reduce circulating white blood cells, then stimulate hematopoietic stem cells to generate new ones during refeeding. It is a logical, energy-efficient strategy: during scarcity, the body prunes older or less efficient immune cells, then repopulates when food returns. Hormones adjust. Growth hormone rises significantly in many people during longer fasts, which conserves muscle mass and supports lipolysis. Thyroid hormone conversion can shift, sometimes lowering triiodothyronine (T3) as the body conserves energy. So is the body “regenerating” during a 72 hour fast? Parts of it, in a limited and context-dependent way: more autophagy, some degree of immune cell turnover, and a metabolic environment that tends to favor cleanup over growth. What we do not have is strong human evidence that a single 72 hour fast “resets” your immune system or broadly regenerates organs in a way that would translate into dramatic long term health improvements on its own. Human data: what is known, what is not Most of the eye catching claims about prolonged fasting and regeneration trace back to work by Valter Longo, PhD, and colleagues. In mice, cycles of prolonged fasting led to: Reductions in IGF-1 and other growth signals associated with aging Increased autophagy Enhanced hematopoietic stem cell driven regeneration of white blood cells after refeeding Benefits in models of autoimmunity and chemotherapy toxicity In humans, the data set is smaller and more nuanced: Fasting mimicking diets. Instead of strict water fasting, Longo’s group tested a 5 day very low calorie, low protein “fasting mimicking diet.” In small trials, participants saw reductions in IGF-1, blood pressure, and trunk fat, and favorable changes in certain inflammatory markers. There were hints of immune cell profile shifts, but not the dramatic “wipe and replace” seen in mice. Shorter fasts. Intermittent fasting and time restricted eating have more human data, especially for metabolic benefits: improved insulin sensitivity, weight loss, and possibly better blood pressure and lipids. These protocols rarely reach the 72 hour mark. True 72 hour water fasts. Here, human data is mostly from small experimental studies or observational reports, often with fewer than a few dozen participants. Outcomes like weight loss, ketone production, blood pressure, and subjective well being improve in many people. Markers of autophagy in humans are harder to measure directly, so much of what we infer comes from known physiology and animal data. As a clinician, I interpret the current state like this: a 72 hour fast probably increases autophagy meaningfully and may nudge certain stem cell populations to be more active during refeeding. It is very unlikely to regenerate organs in any dramatic way, and certainly not on the level of what we attempt with regenerative medicine procedures like stem cell injections or tissue engineering. Does fasting for 72 hours regenerate cells? The honest answer is: it depends what you mean by “regenerate,” but for most people the effect is modest, localized, and heavily dependent on what you do afterward. Here is a pragmatic breakdown: Cellular cleanup is very likely. Autophagy and related processes help cells remove damaged proteins, misfolded structures, and old mitochondria. A sustained period of nutrient deprivation is one of the better triggers we know. This cleanup is a key part of healthy cellular renewal. Some stem cell activation is plausible. In animal studies, hematopoietic and intestinal stem cells respond strongly to fasting and refeeding cycles. In humans, we suspect similar patterns, but do not have large scale, robust data. If stem cells are stimulated, the effect will be most evident in fast turnover tissues like blood and gut. Tissue level regeneration is limited. You are not regrowing cartilage or reversing a long standing tendon tear with a weekend fast. Chronic joint or spine damage, for instance, usually requires mechanical unloading, targeted rehab, and sometimes regenerative injections to see structural improvement. The benefit is cumulative. If you pair periodic fasting with resistance training, nutritional adequacy on eating days, sleep, and management of chronic diseases, you are likely to see significantly better function and longevity over time. A single isolated 72 hour fast is more like a metabolic stress test than a magic reset. So yes, fasting for 72 hours probably supports certain regenerative processes at the cellular level, especially cleanup and turnover in rapidly renewing tissues. No, it is not a substitute for comprehensive care, nor is it a guarantee of long term benefits. When a 72 hour fast is a bad idea In clinic, I spend more time talking people out of unsupervised prolonged fasting than talking them into it. The risks are real, especially if you have underlying conditions, take medications, or have a history of disordered eating. Here is a concise list of people who should completely avoid a 72 hour water-only fast unless they are in a formal, medically supervised program: Those with type 1 diabetes or advanced type 2 diabetes on insulin or sulfonylureas Pregnant or breastfeeding individuals Anyone with a history of eating disorders, especially anorexia or bulimia People who are underweight, frail, or have significant unintentional weight loss Patients with advanced heart, kidney, or liver disease There are other gray zones. People on blood pressure medication, those with a history of gout, and those on multiple psychiatric medications need a careful, individualized plan and close monitoring if they fast beyond 24 hours. Electrolyte disturbances, severe hypotension, and mood changes are all possible. If someone is curious about fasting, I usually start with 12 to 16 hour overnight fasts, then progress gradually. Jumping straight to 72 hours is like going from couch to ultra-marathon with no training. Where fasting and regenerative medicine intersect Regenerative medicine is a broad, sometimes overhyped field that aims to repair, replace, or restore damaged cells, tissues, or organs. Patients come in asking: What is a regenerative medicine doctor exactly, and how does that connect to something as simple as not eating for a few days? A regenerative medicine doctor is usually a physician trained in a core specialty such as orthopedics, physical medicine and rehabilitation, sports medicine, internal medicine, or sometimes neurology, who then develops focused expertise in treatments that harness the body’s own repair mechanisms. That can include platelet rich plasma (PRP) injections, autologous stem cell procedures (using your own cells), certain scaffold or matrix implants, and in some cases biologic drugs that influence tissue regeneration. The most effective regenerative programs I have seen combine procedural therapies with systemic strategies. Metabolic health, sleep, resistance training, and nutrition directly affect how well your tissues respond to PRP or stem cell injections. Fasting sits squarely in that systemic bucket. A metabolically flexible person who tolerates light fasting, maintains a healthy weight, and has good glycemic control heals more predictably after a regenerative procedure than someone with uncontrolled diabetes and chronic inflammation. So while fasting is not regenerative medicine in the procedural sense, it can influence the internal environment in which regenerative therapies operate. The biggest problems and disadvantages of regenerative medicine Patients often arrive with sky high expectations, in part because they have heard stories from athletes or celebrities. Joe Rogan, for instance, has spoken frequently about receiving stem cell treatment in Panama, specifically at the Stem Cell Institute in Panama City, for joint and back issues. Clinics like that operate in a relatively permissive regulatory environment, which allows them to use cell types and Integrated Spine, Pain and Wellness Regenerative Medicine Doctor Scottsdale protocols that are not approved in the United States. This highlights several core problems in the field. To keep it concrete, here are five of the most important disadvantages and challenges in regenerative medicine today: Variable evidence quality. Some uses, like PRP for certain tendon injuries, have decent randomized trial data. Others rely on case series, registry data, or marketing claims with very little rigorous backing. Regulatory gray zones. In the United States, the FDA tightly regulates expanded or culture grown stem cells, but allows some minimally manipulated autologous preparations. Other countries have looser rules, which can attract “stem cell tourism” without strong safety oversight. Cost and access. Many regenerative procedures are expensive and not covered by insurance, putting them out of reach for most patients. Training and standards. “Regenerative medicine” is not a protected term. A weekend course can turn a physician or chiropractor into a self described expert, even if they lack deep training in imaging, anatomy, or orthobiologics. Unrealistic expectations. Marketing often implies near miraculous recovery, which does not align with the incremental gains I typically see in real clinic populations. Beyond those systemic problems, individual patients can experience clear disadvantages: out of pocket costs, travel burden, variable pain during and after procedures, and the emotional toll of hope followed by partial or no improvement. Costs, insurance, and financial realities Money questions come up in almost every consultation. People ask: What is the average Regenerative Medicine Doctor Scottsdale cost of regenerative medicine? Will insurance pay for regenerative medicine, or for something specific like Kinetix injections? How much do regenerative medicine doctors make, and does that create conflicts of interest? The financial landscape is complicated and varies widely by country and by procedure, but a few patterns hold in the United States. For musculoskeletal regenerative procedures such as PRP or bone marrow derived cell injections, typical cash prices range from about 500 to 2,000 USD for standard PRP, and 2,000 to 8,000 USD or more for stem cell based procedures involving bone marrow or adipose tissue. Complex multi site treatment plans can exceed those numbers. What is the average cost of regenerative medicine, broadly speaking? If you force a general range, many common orthopedic biologic treatments land somewhere between 1,500 and 6,000 USD per episode of care, depending on complexity and geography. Will insurance pay for regenerative medicine? For most biologic injections, the current answer in the United States is no. Some carriers are beginning to reimburse certain PRP indications, and occasionally adjunctive biologics used during surgery, but the majority of PRP and cell based procedures remain self pay. Patients specifically ask: Does insurance cover Kinetix? Kinetix is a brand associated with certain regenerative or orthobiologic treatments marketed for joint pain. Coverage depends on the exact product, how it is billed, and the insurance plan, but practically speaking, most insurers still categorize these treatments as experimental and deny payment. I always tell patients to assume a cash model unless they see a written preauthorization from their insurer. On the physician side, how much do regenerative medicine doctors make is hard to answer precisely, because very few are coded as such. Income tracks more with the underlying specialty. In most surveys, the highest paid doctor specialty categories include neurosurgery, orthopedic surgery, cardiology, and some interventional fields, often in the 600,000 to 1,000,000 USD per year range at the top end. The lowest paying doctor specialty categories tend to include pediatrics, family medicine, and some primary care oriented fields, often in the 200,000 to 260,000 USD per year range. A regenerative medicine oriented orthopedist who runs a high volume cash-based clinic will sit much closer to the high income side than a primary care physician who occasionally refers for PRP. Financial incentives do matter. When a physician’s income depends heavily on performing expensive, non covered injections, patients have to rely even more on the doctor’s integrity. I encourage people to ask directly about success rates, alternatives, and whether the physician would recommend the same procedure to a close family member. Pain, success rates, and who makes a good candidate Another frequent concern is whether regenerative medicine is painful. Most regenerative injections involve needles, sometimes guided by ultrasound or fluoroscopy. With good local anesthesia, many patients describe the procedures as uncomfortable but tolerable, similar to a dental visit. The post procedure period can be more challenging, especially with PRP or bone marrow derived injections to joints or tendons, because we often provoke inflammation as part of the healing response. Expect soreness that can last days to a couple of weeks, along with temporary activity restrictions. What is the success rate of regenerative medicine? That phrase is almost meaningless without specifying the condition, the treatment, and the definition of success. For example: PRP for chronic tennis elbow has reasonable data suggesting that a majority of patients, often in the 60 to 80 percent range, report meaningful pain reduction and functional improvement compared with steroid injections or placebo, especially over 6 to 12 months. Stem cell like injections for knee osteoarthritis show a more mixed picture. Some trials and case series report significant pain relief and functional gains in perhaps half to two thirds of patients, others show more modest or no benefit compared with hyaluronic acid or physical therapy. Structural regeneration of cartilage visible on MRI is less consistent than symptom relief. Who is a good candidate for regenerative medicine depends on several practical factors: the nature and severity of the injury or degeneration, the patient’s metabolic and overall health status, their willingness to commit to rehabilitation, and their financial situation. A middle aged patient with a focal tendon tear, good metabolic health, and realistic expectations is a far better candidate than someone with end stage bone on bone osteoarthritis who is hoping to avoid an inevitable joint replacement with one injection. Interestingly, fasting and other metabolic interventions can move someone from marginal to better candidate by improving inflammation, insulin resistance, and body weight. I have seen patients who lost 10 to 20 percent of their body weight and improved their sleep and blood sugar achieve better, more durable results from regenerative procedures. Is there a “best country” for stem cell treatment? Patients sometimes phrase it bluntly: What country is best for stem cell treatment? They have heard about Panama, Mexico, Germany, or clinics in Eastern Europe, often through athletes or podcasts. The reality is uncomfortable. Countries like Panama and Mexico host clinics that use cell preparations, doses, and routes of administration that go beyond what is allowed in the United States. Some are run by capable teams with genuine scientific intent, others are barely regulated businesses. Rigorous outcome data across large numbers of patients is sparse. From a strictly evidence based standpoint, no country can honestly claim to be “best” right now. The United States lags in access but has tighter safety oversight for approved uses. Some European systems have strong academic programs, but patients may not qualify for trials. Countries with more liberal regulations offer access, but at the cost of weaker safety and efficacy data. My advice is to focus less on geography and more on: The specific condition you want treated The type of cells and delivery method proposed The clinic’s data, including complication rates and long term follow up The transparency of their consent process and willingness to discuss alternatives A weekend fast at home will not substitute for any of this, but it is a reminder that powerful biological shifts are still accessible without getting on a plane. How to think about 72 hour fasting in a long term plan Instead of chasing a singular “regenerative” fast, I encourage people to think in terms of cycles and context. A person in their 30s or 40s with no major medical issues who eats a whole food diet, maintains a healthy weight, exercises regularly, and sleeps well will get more from an occasional 24 to 48 hour fast than a metabolically unhealthy person will get from a heroic 72 hour water fast once a year. If you are curious and medically appropriate, it is reasonable to: Start with daily time restricted eating, such as a 12 to 14 hour overnight fast, then gradually explore 16 hours once a week. Monitor how your energy, mood, and blood sugar respond. Work with your physician if you take medications, especially for blood pressure, diabetes, or mood disorders. Once you are comfortable and stable with shorter fasts, a carefully planned 24 hour fast can extend the metabolic benefits, often without major side effects. Continue to prioritize hydration, electrolytes, and good nutrition on eating days. Only after you and your clinician are confident about these shorter fasts should you even consider a 48 to 72 hour fast, and even then, it may not add much beyond what consistent, moderate interventions already achieve. Fasting is a tool, not an identity. Used wisely, it can support the same cellular processes that regenerative medicine aims to harness: better autophagy, healthier mitochondria, and more resilient tissues. Used recklessly, it can aggravate underlying conditions and distract from more important work like strength training, blood sugar control, and addressing sleep apnea. The promise of regeneration is seductive, whether it comes from a clinic overseas or a three day fast at home. The real gains usually arrive quietly, over months and years, built from hundreds of small, repeatable choices rather than a single dramatic intervention.Integrated Spine, Pain and Wellness 7425 E Shea Blvd Suite 102, Scottsdale, AZ 85260 4806608823